11:55 AM
Dec 07, 2018
 |  BC Extra  |  Preclinical News

UCSD team offers access to newly identified antimalaria leads

A University of California San Diego team has published openly 631 antimalaria compounds identified through a screening campaign, offering the potential building blocks of a chemical vaccine that targets malaria in the early stages of infection. All 538,273 screened compounds are built from commercially available chemical scaffolds, giving vaccine developers quick access to the fresh leads.

Most commercial antimalarials, such as artemisinin-based combination therapies, target asexual malaria in the bloodstream; however,...

Read the full 335 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >